Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)

Condition:   Primary Hyperparathyroidism Interventions:   Drug: Cinacalcet;   Drug: Placebo Sponsor:   Amgen Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials